Pubdate: Sun, 27 Jan 2002 Source: Knoxville News-Sentinel (TN) Copyright: 2002 The Knoxville News-Sentinel Co. Contact: http://www.knoxnews.com/ Details: http://www.mapinc.org/media/226 Author: Maura Lerner Cited: Marijuana Policy Project http://www.mpp.org/ MARIJUANA-LIKE DRUG IS DISAPPOINTMENT IN MAYO STUDY A marijuana-like drug was less effective than standard treatment in helping cancer patients fight appetite loss and weight loss, researchers at the Mayo Clinic say. Their study disappointed scientists who had hoped to find a better way of treating a problem that plagues more than half of patients with advanced cancer. The researchers compared Marinol, a synthetic version of THC, one of the active ingredients in marijuana, with a drug that's routinely used to curb appetite loss, megestrol acetate, in 469 people with advanced cancer. They found that 49 percent of those taking Marinol reported improved appetite, compared with 75 percent on megestrol. In addition, only 3 percent of the Marinol group gained weight, compared with 11 percent of the megestrol group. "These findings should dampen enthusiasm for using marijuana derivatives for this purpose," said Dr. Aminah Jatoi, a Mayo clinic oncologist and an author of the study, which appeared in the January issue of the Journal of Clinical Oncology. She said this was the first such study of its kind. However, it's not likely to sway supporters of medical marijuana use. "What's striking about the study is it didn't use marijuana ... so it certainly tells you nothing about marijuana itself," said Bruce Mirken, a spokesman for the Washington-Based Marijuana Policy Project. He said marijuana contains 60 active chemicals in addition to THC, while Marinol, the brand name for the drug dronabinol, contains just THC (tetrahydrocannabinol). "We think it's very important that these sorts of studies on Marinol not be used erroneously to rule out the efficacy of marijuana," he said. But Jatoi said that wasn't their goal. "We did this study hoping that something would have been better than the standard treatment," she said. - --- MAP posted-by: Richard Lake